Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Slattery

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
Pharmaceutical Research|January 1, 1991
Dose-dependent pharmacokinetics of the aldose reductase inhibitor imirestat in manR K Brazzell, P R Mayer, R Dobbs, et al.
Clinical Pharmacology and Therapeutics|November 1, 1989
Lack of effect of cimetidine on acetaminophen disposition in humansJ T Slattery, T I McRorie, R Reynolds, et al.
Clinical Pharmacology and Therapeutics|November 1, 1995
Metabolism of dapsone to its hydroxylamine by CYP2E1 in vitro and in vivoA K Mitra, K E Thummel, T F Kalhorn, et al.
Anesthesiology|May 1, 1989
Effect of thermal injury on the pharmacokinetics and pharmacodynamics of atracurium in humansP H Marathe, J F Dwersteg, E G Pavlin, et al.
Clinical Pharmacology and Therapeutics|March 1, 1996
Inhibition of sulfamethoxazole hydroxylamine formation by fluconazole in human liver microsomes and healthy volunteersA K Mitra, K E Thummel, T F Kalhorn, et al.
British Journal of Clinical Pharmacology|February 1, 1991
Inhibition of the metabolism of paracetamol by isoniazidM M Epstein, S D Nelson, J T Slattery, et al.
Clinical Pharmacology and Therapeutics|June 29, 2000
Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adultsK E Thummel, J T Slattery, H Ro, et al.
Clinical Pharmacology and Therapeutics|August 1, 1993
Inhibition and induction of cytochrome P4502E1-catalyzed oxidation by isoniazid in humansR Zand, S D Nelson, J T Slattery, et al.
Bone Marrow Transplantation|March 1, 1996
Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levelsT Demirer, C D Buckner, F R Appelbaum, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1996
Protein-reactive metabolites of carbamazepine in mouse liver microsomesJ H Lillibridge, B M Amore, J T Slattery, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Pharmaceutical Research|January 1, 1991
Dose-dependent pharmacokinetics of the aldose reductase inhibitor imirestat in manR K Brazzell, P R Mayer, R Dobbs, et al.
Clinical Pharmacology and Therapeutics|November 1, 1989
Lack of effect of cimetidine on acetaminophen disposition in humansJ T Slattery, T I McRorie, R Reynolds, et al.
Clinical Pharmacology and Therapeutics|November 1, 1995
Metabolism of dapsone to its hydroxylamine by CYP2E1 in vitro and in vivoA K Mitra, K E Thummel, T F Kalhorn, et al.
Anesthesiology|May 1, 1989
Effect of thermal injury on the pharmacokinetics and pharmacodynamics of atracurium in humansP H Marathe, J F Dwersteg, E G Pavlin, et al.
Clinical Pharmacology and Therapeutics|March 1, 1996
Inhibition of sulfamethoxazole hydroxylamine formation by fluconazole in human liver microsomes and healthy volunteersA K Mitra, K E Thummel, T F Kalhorn, et al.
British Journal of Clinical Pharmacology|February 1, 1991
Inhibition of the metabolism of paracetamol by isoniazidM M Epstein, S D Nelson, J T Slattery, et al.
Clinical Pharmacology and Therapeutics|June 29, 2000
Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adultsK E Thummel, J T Slattery, H Ro, et al.
Clinical Pharmacology and Therapeutics|August 1, 1993
Inhibition and induction of cytochrome P4502E1-catalyzed oxidation by isoniazid in humansR Zand, S D Nelson, J T Slattery, et al.
Bone Marrow Transplantation|March 1, 1996
Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levelsT Demirer, C D Buckner, F R Appelbaum, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1996
Protein-reactive metabolites of carbamazepine in mouse liver microsomesJ H Lillibridge, B M Amore, J T Slattery, et al.
Pageof 12